4D Molecular Therapeutics, Inc.

FDMTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$85.2M

▲ 230194.6% YoY

Net Income

-$140.1M

▲ 12.9% YoY

EPS

$-2.42

▲ 18.8% YoY

Cash

$60.2M

▼ 59.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.